Thu Jan 29 16:14:33 SGT 2015  
    Hair loss, Singapore (SG)

Hair loss, Singapore (SG)


Hair loss, Singapore (SG) @singaporehair_com: Hair loss treatment clinic, Singapore


Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic:
168 Bedok South Avenue 3 #01-473
Singapore 460168
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Hair loss, Singapore (SG)
Opening Hours
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.


Latest News

Using stem cells to grow new hair
Tue, 27 Jan 2015 14:59:19 +0100 | ScienceDaily Headlines
Researchers have used human pluripotent stem cells to generate new hair. The study represents the first step toward the development of a cell-based treatment for people with hair loss. In the United States alone, more than 40 million men and 21 million women are affected by hair loss. (Source: ScienceDaily Headlines)

The genetics of alopecia areata: new approaches, new findings, new treatments
Tue, 27 Jan 2015 00:00:00 +0100 | Journal of Dermatological Science
(Source: Journal of Dermatological Science)

Fluorinated Nanoparticles Enable Multimodal Imaging
Mon, 26 Jan 2015 06:01:27 +0100 | NanoFocus
Laser-induced baldness of hairy nanoparticles allows imaging techniques to work nicely together (Source: NanoFocus)

What is the Remission Rate for Antithyroid Drug Treatment for Hyperthyroidism in Children?
Mon, 26 Jan 2015 00:01:37 +0100 |

Hair Loss in Women
Sat, 24 Jan 2015 05:22:20 +0100 | Clinical Obstetrics and Gynecology
Hair loss is a common cause of morbidity for many women. As a key member of the woman’s health care team, the obstetrician/gynecologist may be the first person to evaluate the complaint of hair loss. Common types of nonscarring hair loss, including female pattern hair loss and telogen effluvium, may be diagnosed and managed by the obstetrician/gynecologist. A systematic approach to diagnosis and management of these common forms of hair loss is presented. (Source: Clinical Obstetrics and Gynecology)

Update on Male Pattern Hair Loss.
Sat, 24 Jan 2015 01:01:21 +0100 | Journal of Drugs in Dermatology
Authors: Santos LD, Shapiro J

The clinical patterns of vitiligo “hospital-based study” in Makkah region, Saudi Arabia
Sat, 24 Jan 2015 00:00:00 +0100 | Journal of Dermatology and Dermatologic Surgery
Conclusions The patients were predominantly females, with a large proportion having a positive family history. The mean age of onset of vitiligo in our study was 24.5years. It was commonly associated with thyroid disorders. Localized vitiligo was the most prevalent type. (Source: Journal of Dermatology and Dermatologic Surgery)

Phase II Study of Nab-Paclitaxel and Bevacizumab as First-line Therapy for Patients with Unresectable Stage III and IV Melanoma
Fri, 23 Jan 2015 23:12:49 +0100 | American Journal of Clinical Oncology
Conclusions: In this phase II multicenter study, this doublet had significant activity in patients with metastatic melanoma, and was well tolerated. These results are promising and follow-up trials to further explore this regimen are warranted. (Source: American Journal of Clinical Oncology)

Health Tip: Health Conditions May Lead to Hair Loss
Fri, 23 Jan 2015 07:00:00 +0100 | MedicineNet Skin General
Title: Health Tip: Health Conditions May Lead to Hair LossCategory: Health NewsCreated: 1/23/2015 12:00:00 AMLast Editorial Review: 1/23/2015 12:00:00 AM (Source: MedicineNet Skin General)

Platelet-Rich Plasma: Applications in Dermatology
Fri, 23 Jan 2015 00:00:00 +0100 | Actas Dermo-Sifiliograficas
Publication date: Available online 20 January 2015 Source:Actas Dermo-Sifiliográficas (English Edition) Author(s): E. Conde Montero , M.E. Fernández Santos , R. Suárez Fernández In recent years, the use of platelet-rich plasma has increased notably in a range of diseases and settings. Uses of these products now go beyond skin rejuvenation therapy in patients with facial ageing. Good outcomes for other dermatological indications such as skin ulcers and, more recently, alopecia have been reported in case series and controlled studies. However, these indications are not currently included in the labeling given that stronger scientific evidence is required to support their real benefits. With the increased use of these products, dermatologists need to become familiar with the underlying ...